Sodium iodide (131I) capsules for therapeutic use
| Primena | hyperthyroidism (treatment of Graves’ disease, toxic multinodular goitre or autonomous nodules), treatment of papillary and follicular thyroid carcinoma including metastatic disease |
| Farmaceutski oblik | capsule, hard |
| Veličina pakovanja | polypropylene vial, closed with polypropylene stopper, placed in a lead container. One vial contains a single capsule. |
| Sadržaj po bočici | sodium iodide (131I) activities of 111 – 3700 MBq at time of calibration 260 mg of sodium hydrogen phosphate (Na2HPO4) 0.8 mg sodium thiosulfate (Na2S2O3) |
| Karakteristike rastvora | radionuclidic purity: > 99.9 % radiochemical purity: > 95 % |
| Kalibracija | at the user's request |
| Rok upotrebe | 21 days from the production date |
| Čuvanje | at temperature below 25 ºC, zaštićeno od vlage |
| Isporuka | on request |
